CMS advised Tubulis on the deal, Baker McKenzie advised Andera Partners, Evotec and Fund+ on the deal. Biotech company Tubulis has successfully completed a Series B […]
Tubulis’ €60 Million Series B Financing Round
Centauri Therapeutics’ $32 Million Series A Investment
Goodwin advised BIVF, Novo and Evotec on the deal. Boehringer Ingelheim Venture Fund GmbH (“BIVF”), Novo Holdings REPAIR Impact Fund (“Novo”) and Evotec SE (“Evotec”) led […]
Aptuit Srl’s Acquisition of R&D Center from GlaxoSmithKline
IN BRIEF: CBA, Macchi Di Cellere Gangemi, advised on the matter. CBA advised Glaxo Group Limited, Glaxosmithkline Finance Plc, Glaxosmithkline Research & Development Limited, Setfirst Limited […]